This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignees: Natco Pharma Limited, Other. Active years: 2013-2020.
Company Filing History:

Years Active: 2013-2020
Title: Innovations and Contributions of Inventor Ramakrishna Pilli
Introduction
Ramakrishna Pilli is a notable inventor based in Hyderabad, Telangana, India. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-cancer agents. With a total of two patents to his name, his work reflects a commitment to advancing medical science and improving treatment options.
Latest Patents
Ramakrishna Pilli's latest patents include a modified process for the preparation of Ceritinib and an amorphous form of Ceritinib. This invention relates to an improved process that achieves high yield and purity, making it cost-effective and feasible for large-scale production. Additionally, he has developed a stable amorphous form of Ceritinib and a process for preparing Crystalline form A of Ceritinib. His second patent involves pyrazolo[3,4-D]pyrimidine derivatives as anti-cancer agents. This invention encompasses substituted pyrazolo[3,4-d]pyrimidine derivatives that exhibit anti-proliferative activity, making them useful in treating various cancers.
Career Highlights
Throughout his career, Ramakrishna Pilli has worked with prominent companies, including Natco Pharma Limited. His experience in the pharmaceutical industry has allowed him to contribute to significant advancements in drug development and formulation.
Collaborations
Ramakrishna has collaborated with notable professionals in his field, including Durga Prasad Konakanchi and Subba Rao Pula. These collaborations have further enriched his research and development efforts.
Conclusion
Ramakrishna Pilli's innovative work in the pharmaceutical sector demonstrates his dedication to improving healthcare through scientific advancements. His patents reflect a strong commitment to developing effective treatments for cancer, showcasing his impact on the industry.